Technology solutions for a better world.

The VIC Investor Network (VIN) invests in companies with exceptional intellectual property foundations in healthcare and emerging technology areas

Browse Companies

Register for a VIC Investor Network Webinar

Angel investing with confidence

VIN addresses the primary challenges of angel investing in science and technology-driven innovation

Issues of Angel Investing

Register for a VIC Investor Network Webinar


Co-investment on same terms with larger investors and built-in investment safeguards

Investor Protections

Register for a VIC Investor Network Webinar


Investments may be made as low as $5k per invested company allowing more investments and portfolio diversification


Register for a VIC Investor Network Webinar


Secondary market for VIN shares gives members opportunity for liquidity prior to portfolio exits


Register for a VIC Investor Network Webinar

VIC’s Innovation Ecosystem

Technology Venture Development

Turnkey support through all stages of portfolio companies’ development.

Learn More

VIC Foundry

Incubate high-potential ideas for future VIC portfolio companies.

Learn More

VIC Investor Network

Equity funding for proof-of-concept through commercial product roll-out.

Learn More

VIC Venture Fund

Series A/B funding to reach major value-enhancing milestones

Learn More

Latest News

More News

Our Portfolio Companies

Companies built from the ground up based on high impact technologies exclusively licensed from top research institutions around the world. View All Companies

Now Funding Akeso Biomedical

Akeso Biomedical is an animal performance and food safety company developing new solutions to improve gut health and treat bacterial infections using a broad-spectrum chemistry. View Details
Now Funding BiologicsMD

BiologicsMD is developing highly targeted, novel human therapeutics for hair loss diseases and conditions, as well as severe bone disorders. View Details
Now Funding Neurexis Therapeutics

Neurexis Therapeutics is Neuroprotective Innovation for Human Health View Details
Ascendant Dx

ACQUIRED | Ascendant Dx is a bioscience company whose mission is to commercialize disruptive diagnostic technologies aiding identification and treatment for diseases of women and children.

View Details

ACQUIRED | BlueInGreen (BIG) designs, manufactures and services the most efficient gas dissolution equipment for water and wastewater treatment. View Details

Calyxo is developing a disruptive solution for kidney stone removal that is faster, easier, and better for patients, clinicians and hospitals.

View Details
View All Companies